About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICPO Foundation Announcing Official Launch of Its ICPO Academy for Theranostics During Its 3rd Forum for Theranostics in Precision Oncology on October 12th and 13th in Garching Munich

By: via Business Wire

This October 12th and 13th, 2023, the International Centers for Precision Oncology (ICPO) Foundation has successfully hosted its 3rd ICPO Forum for Theranostics in Precision Oncology physical on the Science Campus in Garching Munich. The Forum is a bi-annual tradition for the German foundation which is working to enable growing numbers of Cancer Patients worldwide to get access to highly effective diagnostics and treatments in Radiomolecular Precision Oncology.

At the occasion of its 3rd Forum, the ICPO Foundation has officially launched its ICPO Academy for Theranostics. The main objective of the Academy programme is to disseminate knowledge in Radiomolecular Precision Oncology in order to improve the outcome of a patient treated with radiopharmaceutical therapies, and consequently to ensure sustainable patient access at a global scale.

This was a perfect time for the ICPO Foundation to acknowledge the Public Private Partnership between the Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) and Isotope Technologies Munich SE (ITM) which made the successful Chinese pilot project of the Academy possible, allowing over 700 users to take part and 340 to obtain certifications. From the inception of the project, the two partners have played a key role in supporting world leading experts from the field to share knowledge and invest time and efforts in creating and contributing to the pilot unique curriculum and content.

The ICPO Academy for Theranostics offers a comprehensive online educational programme, developed by the ICPO Foundation and powered by its global Community of experts. It features over 50 hours of content taught by over 30 leaders and experts. The content is available in different languages. The primary audiences of the ICPO Academy for Theranostics are clinicians, researchers, physicists and radiochemists as well as nurses and technologists, who seek to integrate Radiomolecular Precision Oncology in patient care.

The curriculum by the ICPO Academy for Theranostics has been developed under the guidance of its President, Prof. Richard P. Baum, world leader and pioneer in Nuclear Medicine and Radiomolecular Precision Oncology, together with prominent Pillar Leaders, international experts in their respective field, namely Prof. Vikas Prasad, Prof. Thomas Beyer, Prof. Frank Rösch, Linda Gardner and Josh Mailman. Thanks to their extensive cumulated knowledge and experience as well as personal dedication, they have crafted an exclusive and comprehensive online educational programme that engages over 30 carefully selected Faculty to cover each of the teaching units.

An international certification issued by the ICPO Foundation validates the educational achievements of the participant. Additionally, the ICPO Academy for Theranostics is awaiting accreditation as continued medical education as well as will expand by adding new content developed with and endorsed by prestigious societies, institutions and organisations in the field of Nuclear Medicine globally.

As the ICPO Foundation aims at widening accessibility to education as well as its scalability worldwide, a matching plan is offered to members of the academic community. In practice those may apply for stipends sponsored by third party organisations active in their geography. In return these organizations would reinforce their collaborative and sustainable positioning in the given markets as well as would gain in visibility in terms of talent pool development and further education needs in the field of Radiomolecular Theranostics.

In summary, by officially launching the Academy for Theranostics, the ICPO Foundation is better positioned than ever to support its Community and to enable the global expansion of patient access in Precision Oncology!

All valuable information about the ICPO Academy for Theranostics can be found at www.theranostics.academy. Moreover, to make a donation or become a Member of the ICPO Foundation, as Friend, Supporter or Partner, please visit www.icpo.foundation.

About ICPO Foundation

The International Centers for Precision Oncology Foundation (ICPO) is a non-profit organization established in 2019 under German law by leading international medical practitioners and life sciences entrepreneurs. Recognizing a paradigm shift in cancer care from one size fits all to a personalized approach, the ICPO Foundation is helping to build momentum to scale global patient access to Radionuclide Molecularly Targeted Precision Oncology to support this shift. To scale patient access, the ICPO Foundation aims to develop an international network of physical diagnostic and therapeutic Centers for Precision Oncology organized in a Social Franchise model based on shared know-how, certified education, and design and process standardization that enables best clinical practice globally. Furthermore, it is the ICPO Foundation’s objective to empower its Centers by embedding them in a highly inclusive Community that spearheads its model and lives up to the Precision Oncology promise, by making it available to all patients in need, irrespective of country or social status.

Recently the ICPO foundation has closed collaborations with renowned medical associations such as WARMTH (World Association of Radiopharmaceuticals and Molecular Therapies) and is establishing the ICPO Academy for Theranostics as a globally available e-learning platform.

Learn more at: www.icpo.foundation and www.theranostics.academy

Contacts

More News

View More
FICO’s Big Dip Could Be the Best Buying Chance of the Year
Via MarketBeat
Tickers EFX FICO
D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
Via MarketBeat
Tickers QBTS RGTI
Datavault: A Speculative AI Play, But Beware of Volatility
Via MarketBeat
Topics Artificial Intelligence
Tickers DVLT IBM SCLX
Traders Are Piling Into Suncor Call Options—Should You?
Via MarketBeat
Topics World Trade
Tickers SU
Delta Air Lines Stock Looks Ready to Fly to New Highs
Via MarketBeat
Tickers DAL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.